VIA Pharmaceuticals, Inc. (VIAP)

[downsideup]

I don't know...

I'm still not able to avoid being made suspicious re the nature of what seems a highly dilutive, basically day to day financing deal with their sposor that is in place now... and I note the accelerating trend in distribution since the run up in June.

I don't expect that the effort that was made to bring new targets in house should be seen in any way as a negative... rather than as a potential benefit available to VIAP from knowing more about those targets, and their relationship to current research results, given new awareness of the nature of the problems they address that others may not have. But, that still doesn't give me many warm fuzzies about the near term nature of the commitment that the financiers at Bay are NOT making here yet, based on expectations tied to wrapping up the final elements in the current phase II.

I don't think the results that will be reported out after wrapping up the current phase II are going to prove to be much of a surprise... at least not to anyone at Bay. Maybe it is going to be a big deal... and they are just downplaying it now, posturing it as if they think there is WAY more risk than exists, in order to gain a larger benefit from diluting your current interest now, with a tenuous day to day financing arrangement.

Doesn't "feel" to me like it is only that, though...

I don't see much has changed since my last post here, a bit over two months ago:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=41841586

The one thing I see that does look a bit different from then... is the look in the short term charts. Maybe it will pop back up nearer to $0.50 again in the near term... or at least level off here, and stop the slide, with a move back to the top of the bands. Still not feeling it... when Bay could still pull the plug on it at any time. Maybe they'll only do that right after the phase II is wrapped up ?

For now I'll wait and see what happens... a resumption of the slide... or a pinching of bollies before a pop or a drop ?

Might be a trade there... but... I'm not here to trade the market noise, rather than because of an interest in the potential for them to hit it out of the park. A major success in a drug candidate that the phase II shows the majors will have to own... would be nice. I'm not looking for the bunt and a throw to make the out at first... that comes with moving back to re-starting early stage trials with new round of drug candidates.

If that sort of a homerun candidate is what they still have on the line with the current Phase II trial extension... I'll grant you that Bay really ARE doing a pretty good hand playing this hand more like it is a game of poker.